8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer''s disease

Accumulation of oxidative DNA damage has been proposed to underlie aging and neurodegenerative diseases such as Alzheimer's Disease (AD). The DNA adduct 8-hydroxy-2′-deoxyguanosine (8OHdG) is considered a good indicator of oxidative DNA damage. To investigate whether this type of DNA damage is involved in AD etiology, 8OHdG levels were determined in postmortem human brain tissue of controls and AD patients (in frontal, occipital, and temporal cortex and in hippocampal tissue). Parametric studies in rat revealed no influences of postmortem delay, repeated freezing/thawing or storage time. In human brain, approximately two 8OHdG molecules were present per 10⁵ 2′-deoxyguanosines. In AD patients and controls, 8OHdG-levels were not related to age, sex, or brain region. Also, no differences were found between controls and AD patients. It was concluded that 8OHdG in nuclear DNA, although present throughout the brain in fairly high amounts, does not accumulate with age, nor does it appear to be involved in AD. More detailed studies are required to extend this conclusion to other types of oxidative damage.     

Molecular analysis of HLA-D region genes in seropositive rheumatoid arthritis

Analysis of HLA DRB1 and DQB1 Bam HI RFLPs revealed four DRB1 (4.8, 5.2, 6.0 and 7.0 kb) fragments and a 3.2 kb DQB1 fragment to be significantly increased in Caucasians with seropositive RA compared to healthy individuals. The 4.8, 5.2 and 7.0 kb DRB1 fragments were found in 86.5% of RA patients and in 56% of the controls (p = 10(-3), relative risk (RR) = 5.0), while the 6.0 kb fragment was found in 79% of RA patients compared to 32% of controls (p = 2 x 10(-5), RR = 8.0). The 3.2 kb DQB1 fragment was observed in 63.5% of RA patients versus 38.0% of controls (p = 10(-2), RR = 2.8). Analysis of these fragments relative to HLA phenotypes revealed that the 4.8, 5.2 and 7.0 kb DRB1 fragments were strongly correlated with DR4, -7, -9 and -w53 serotypes, the 6.0 kb RFLP with DR4 and the 3.2 kb DQB1 fragment with DR1 and DQw1. Using probes specific for the 5' or 3' regions of the DRB1 gene, the 5.2 and 6.0 kb DRB RFLPs were mapped to the 5' end and the 4.8 and 7.0 kb RFLPs to the 3' end of the DRB1 gene. A probe generated from the second exon of the DRB4 (DRw53) gene recognized only the 5.2 and the 6.0 kb RFLPs corroborating the 5' location of these RFLPs. Family studies further confirmed that these RFLP's segregated with HLA phenotypes.     

Dielectric behavior of pulmonary edema induced in the rat lung

The dielectric properties (conductivity, kappa and relative permittivity, epsilon) of excised rat lung are modified by lung air and water content. The measurements of these quantities were made over the frequency range of 10 kHz to 100 MHz with an open-ended coaxial probe. The following relationships were analyzed in an oleic acid-induced pulmonary edema model using 18 animals: the spectra of kappa, epsilon and the loss tangent as a function of lung air and water content. Secondly, an isolated-perfused lung system was produced to induce a gradual increase in lung water. The time course of kappa, epsilon and the loss tangent for one excised lung was analyzed. The principal findings were: (i) a decrease in kappa and epsilon with increasing air content, (ii) an increase in kappa and epsilon with increasing water content, and (iii) a good correlation between lung water content and maximum loss tangent that was insensitive to changes in air content. We conclude that this technique could provide a quantitative assessment of lung water during pulmonary edema formation.     

Cartilage degradation products as markers for evaluation of patients with rheumatic disease

Markers of cartilage degradation hold a great, but so far underutilized potential in the research and clinical management of joint diseases such as osteoarthritis (OA) and rheumatoid arthritis (RA). With the rapid pace of development of such markers, they are likely to emerge as promising clinical tools for several uses. These roles may include: improving preclinical and clinical development in arthritis research; differentiation of patients with high and low turnover states at disease diagnosis; selection of optimal therapy and therapy dose for the individual patient; monitoring disease progression; and predicting disease outcome.This review focuses on the cartilage matrix components and the metabolites from this very special tissue that have been proposed as biochemical markers. Special attention is focused on the challenges facing the development of such markers to the standards required for widespread practical use. Examples are provided on the current use of cartilage derived biochemical markers and perspectives for the future use of markers and required clinical documentation are presented.     

Periodic breathing and genetics

The episodic waxing and waning of ventilation is a fundamental event in sleep apnea syndromes. Post-hypoxic frequency decline (PHFD) and periodic breathing (PB) are evoked by brief hypoxic exposures in unanaesthetized and unrestrained inbred C57BL/6J mice, but not in A/J mice; and expression of PHFD differs not only among these mice strains but in among rat strains as well. These observations along with the current literature on genetic factors that operate on ventilatory behavior at rest and with chemosensory drive lead to the hypothesis that genetic factors infer some proportion of risk for the ventilatory instability observed in human sleep apnea syndromes.     

以单病种过程质量管理促进临床诊疗同质化

单病种质量管理丰富了过程质量管理的内涵,是提升医疗质量管理水平的重要手段。利用单病种过程质量管理实现医疗质量管理同质化,需要从临床诊疗工作同质化、数据同质化、医疗质量评价同质化三方面发力,引导医疗机构运用单病种质量监测信息项开展国家、省级和院内、院际间的质量比较,从而推进临床诊疗过程质量管理同质化。     

川崎病门诊临床路径管理系统构建与应用

川崎病遗留冠状动脉损害长期存在,需要对患儿进行长期监测。借助医院信息系统,设计了川崎病门诊临床路径管理系统。系统具备路径设置、医生工作站路径、科研统计分析、患者预约提醒等功能,可满足川崎病临床治疗和科研需求。但系统使用率、系统操作的精细化水平等有待进一步提升,可从系统支持、临床管理两方面持续改进。     

降低终末期肾病患者动静脉内瘘成熟不良率

目的降低终末期肾病患者动静脉内瘘成熟不良率。方法成立品管圈圈组,通过现状调查、原因解析明确问题真因,从制定动静脉内瘘院前指导规范,建立多学科协作模式;实施“VAP”评估模式,制定围手术期标准化管理流程;构建“互联网 +”智能宣教模式,优化院外延伸服务三方面进行改进。结果终末期肾病患者动静脉内瘘成熟不良率由10.6%降低至3.3%。结论开展品管圈活动降低了终末期肾病患者动静脉内瘘成熟不良率。     

2014—2019年江西省伤害死亡情况及疾病负担分析

目的 了解江西省居民伤害死亡流行情况及其疾病负担,为科学制定本省伤害防制策略和措施提供依据。方法 利用中国死因登记报告信息系统2014—2019年江西死因监测数据,应用Excel 2007和SPSS 17.0软件进行数据整理和分析。采用死亡数、粗死亡率、标化死亡率、构成比、潜在减寿年数（PYLL）、减寿率（PYLLR）和平均潜在减寿年数(AYLL)等指标进行统计学描述,趋势变化采用年度变化百分比（APC）进行分析。结果 2014—2019年江西报告伤害死亡25 638人,年均粗死亡率为 50.81/10万,年均标化死亡率为 49.55/10万。男性死亡率高于女性、城市死亡率高于农村。伤害死亡前5位死因分别为道路交通事故、跌落、溺水、自杀和中毒。溺水、交通事故、跌落分别是0～14岁、15～44和45～64岁、≥65岁的首位伤害死因。2014—2019年江西省前5位伤害死因中,跌落粗死亡率呈上升趋势（APC = 8.22%）,中毒粗死亡率均呈下降趋势。2014—2019年伤害PYLL为692 196.73人年,PYLLR为14.24‰,AYLL 为 33.77年。PYLL及PYLLR 交通事故最高,AYLL最高的为溺水。15～44岁年龄组PYLL最高。结论 江西省伤害死亡负担较重,应根据不同人群的伤害死亡特征制定相应的防控策略和措施。     

1990—2019年中国高血清低密度脂蛋白胆固醇疾病负担趋势分析与预测

目的 描述和分析1990—2019年中国高血清低密度脂蛋白胆固醇（high LDL cholesterol,高LDL - C）疾病负担状况及变化趋势,并预测未来5年的疾病负担,为中国高LDL - C科学防控提供依据。方法 提取2019年全球疾病负担（GBD 2019）中因高LDL - C造成的死亡数、死亡率及DALYs等疾病负担指标,相关指标均采用GBD 2019全球标准人口进行年龄标准化,采用平均年度变化百分比（AAPC）分析率的变化趋势,并应用R 4.1.0对1990—2016年中国因高LDL - C造成的死亡率和DALYs率建立ARIMA模型和NNAR模型,用2017—2019年的数据来评价两模型的拟合效果,最后用拟合效果最好的模型预测2020—2024年中国高LDL - C死亡率和DALYs率。结果 1990—2019年中国高LDL - C造成的死亡率（AAPC = 3.1%,P＜0.05）和DALYs率（AAPC = 2.2%,P＜0.05）整体呈波动上升趋势;标化死亡率和DALYs率增长14.21%和0.56%,男女性别比范围分别为1.33～1.67和1.36～1.76,男性高于女性;年龄别疾病负担≥70岁人群远高于15～49岁和50～69岁群体;ARIMA（0,2,0）和NNAR（1,1）模型预测与实际趋势基本一致,前者预测值与实际值相对误差、均方根误差（RMSE）、平均绝对误差（MAE）以及平均绝对百分误差（MAPE）均较小,预测精度更好。 结论 中国高LDL - C造成的疾病负担呈逐渐上升趋势,在2020—2024年将继续上升。男性、高龄人群疾病负担更加沉重,应采取针对性措施进行干预。